CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Spectral MD Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Spectral MD Holdings Ltd
2515 McKinney Ave.,, Suite 1000,
Phone: (302) 658-7581p:302 658-7581 DALLAS, TX  75201  United States Fax: (302) 655-5049f:302 655-5049
This company was Merged or Acquired on 9/11/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Spectral MD Holdings, Ltd. is a predictive artificial intelligence (AI) company. The Company develops technology using predictive analytics and AI algorithms to help clinicians in making faster treatment decisions in the wound care sector. The Company's DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The Company’s DeepView SnapShot wound imaging device is an internally developed multispectral imaging device, which enables the Company to distinguish between damaged and healthy human tissue invisible to the naked eye, providing day one healing assessments for burn wounds and diabetic foot ulcers (DFU). DeepView’s output is engineered to allow the physician to make an informed decision regarding the treatment of the patient’s wound. Its wholly owned subsidiary is Spectral MD UK Ltd.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022Yes---Yes

Industries
SIC Code Description
7372 Prepackaged software
7374 Computer processing and data preparation and processing services
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board MartinMellish 64 6/22/2021 6/22/2021
Chief Executive Officer WenshengFan 53 6/22/2021 6/22/2021
Chief Financial Officer NilsWindler 12/1/2021 12/1/2021
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 71 (As of 12/31/2022)
Outstanding Shares: 137,404,723 (As of 8/31/2023)
Stock Exchange: LON
Fax Number: (302) 655-5049
Email Address: info@spectralmd.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 7, 2024